Looking for volunteers
CAN-PRIME: Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices
NCT06700304 · Neuralink Corp · Updated 31 May 2025
- What is being tested
- N1 Implant; R1 Robot
- For
- Tetraplegia/Tetraparesis; Quadriplegia; Quadriplegia/Tetraplegia; Cervical Spinal Cord Injury; Amyotrophic Lateral Sclerosis (ALS); Spinal Cord Injury (Quadraplegia); Spinal Cord Injury
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 19 years and older. About 6 people. The full rules are on the registry page.
- Where
- Canada
- When
- Starts or started 20 Nov 2024, ends 30 Nov 2030. Registered 21 Nov 2024.
- Results
- None posted yet.
In the researchers' words
The CAN-PRIME Study is to test the safety and functionality of Neuralink's N1 Implant and R1 Robot in people who have difficulty moving their arms and legs (tetraparesis or tetraplegia). The N1 Implant is a small, wireless device placed in the skull. It connects to tiny threads inserted into the brain by the R1 Robot, which is a machine designed to carefully place these threads. This study will help researchers learn how well the implant and robot work and if they are safe for use.
Sites
- University Health NetworkToronto, Ontario, Canada